Cambridge Innovation Capital
Cambridge, Cambs · Seed–Late Stage · 58 people tracked
Investment thesis
The firm believes that science and technology can drive meaningful change through knowledge-intensive businesses. By providing financial backing and expert guidance, it aims to support pioneering entrepreneurs in life sciences and deep technology to build globally competitive companies that generate both financial returns and societal impact. The firm prioritizes alignment with ESG principles and impact investing as central to its strategy.
Source: firm website, verified Jul 20, 2026.
Team · 58 people
from the firm's websiteWhat they invest in
from 3 of 44 portfolio companiesAI & Machine Learning ×2Biotech ×1Cloud Computing ×1Deep Tech ×1Developer Tools ×1Enterprise Software ×1Healthtech ×1Medical Devices ×1
HQs:United Kingdom×1United States×1
Investments · 44 tracked
founders shown can be your intro pathPretzel Therapeutics develops therapeutics targeting bioenergetic dysfunction and mitochondrial disease by addressing defects in mitochondrial DNA function and gene expression. The company leverages expertise in mitochondrial biology and drug discovery to create treatments for diseases associated with mitochondrial dysregulation.
BiotechDeep TechHealthtechMedical Devices<UNKNOWN>
Jay Parrish(Chief Executive Officer & Chairman of the Board)Michal Minczuk(Co-Founder)Gabriel Martinez(Chief Scientific Officer & Co-Founder)Claes Gustafsson(Co-Founder)
Origami is an AI-powered platform that helps sales teams identify and enrich prospective customers through intelligent prospecting and signal-based lead generation. The company serves modern go-to-market teams seeking to accelerate their sales workflows.
AI & Machine LearningEnterprise SoftwareSaaSSales TechSan Francisco, US
Seldon provides a Kubernetes-native MLOps and LLMOps platform for deploying, scaling, and governing machine learning and AI models in production across any cloud or on-premise environment. The platform combines real-time inference serving, model monitoring, drift detection, explainability, and governance tools for VP Engineering, Chief AI Officers, and AI Platform Architects.
AI & Machine LearningCloud ComputingDeveloper ToolsLondon, GB
Frequently asked questions
- What stage does Cambridge Innovation Capital invest at?
- Cambridge Innovation Capital invests at the Seed, Late Stage stages.
- What sectors does Cambridge Innovation Capital focus on?
- Cambridge Innovation Capital focuses on AI & Machine Learning, Biotech, Deep Tech.
- Where is Cambridge Innovation Capital located?
- Cambridge Innovation Capital is headquartered in Cambridge, Cambs.
Similar investors
A16z is a venture capital firm focused on investing across multiple sectors including AI, American Dynamism, bio and health, consumer, crypto, enterprise, fintech, growth, and infrastructure.
Data Collective identifies and supports ambitious company founders developing technology-driven solutions. The firm focuses on companies using innovation to restore predictability in an unstable world, with demonstrated expertise across clean energy, gene therapy, sustainable agriculture, and machine learning applications in healthcare.
Google Ventures invests in innovative founders across diverse industries, focusing on companies where they can provide value across multiple stages and milestones through long-term relationships.
Khosla Ventures is a venture capital firm investing across consumer and retail, enterprise, fintech, frontier technologies, sustainability, digital health, medtech and diagnostics, and therapeutics sectors.
Jazz Ventures is a venture capital firm with a portfolio spanning healthcare technology, artificial intelligence, digital therapeutics, and human performance optimization across diverse application areas.